Concourse Financial Group Securities, Inc. Brooklyn Immuno Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
BUY
$0.23 - $0.71 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$0.48 - $2.03 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$1.76 - $4.84 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$4.17 - $9.79 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$8.86 - $17.05 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$3.75 - $78.5 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$3.72 - $12.76 $0 - $0
0 New
0 $0

Others Institutions Holding BTX

# of Institutions
1
Shares Held
1.21M
Call Options Held
0
Put Options Held
0
View Full List

About Brooklyn ImmunoTherapeutics, Inc.

BTX Quotes by TradingView
  • Ticker BTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,825,700
  • Description
  • Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...
More about BTX
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email